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A B S T R A C T
The aim of this study was to investigate the effect of 3- weeks stationary cardiac reha-
bilitation on plasma lipids level in patients with CHD. The study included 444 consecu-
tive patients (364 male and 80 female, mean age 58±9 year) with CHD who underwent
3-weeks stationary cardiac rehabilitation. Patients were divided into groups depending
on their baseline levels of cholesterol and medication therapy: patients with normal (< 5
mmol/L, group I, 129 patients) and elevate plasma level of Total cholesterol (> 5 mmol/L,
group II, 315 patients) and subgroups Ia and IIa (with statin in therapy), Ib and IIb
(without statin in therapy). After 3-weeks cardiac rehabilitation, the levels of Total cho-
lesterol 5.75±1.34 vs. 5.17±1.08 mmol/l; p<0.001, triglycerides 2.04±1.33 vs. 1.81±1.06
mmol/L; p=0.004, LDL-cholesterol 3.77 ±1.14 vs. 3.21±0.96 mmol/L; p<0.001 were sig-
nificantly lower while the level of HDL- cholesterol 0.94±0.28 vs. 0.99±0.27 mmol/L;
p=0.008 were significantly higher in comparison with the baseline values. Furthermore,
we found significant changes in lipid profile at the end of rehabilitation in each group of
patients compared with the baseline values. There were no significant differences in
plasma lipids level between group of patients with or without statin in therapy at the
end of rehabilitation. The results of this study suggest that moderate regular physical
activity and diet alone or in combination with hypolipidemic drugs already after 3 we-
eks have a favourable effect on plasma lipids level and should be propagate in the pre-
vention of CHD.
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Introduction
Coronary heart disease (CHD) has an
outstanding socioeconomic character in
contemporary countries because of the
very high rate of morbidity and mortality.
In the United States of America, about
1.5 million people per year get ill from
acute myocardial infarction (MI)1. In the
recent European Heart Survey, mortality
in patients presenting with ST- elevation
acute coronary syndromes was 8.4% at 1
month2. Genetics factors, hyperlipidemia,
hypertension, cigarette smoking, diabe-
tes mellitus, obesity, physical inactivity
and stress are the most important risk
factors for CHD3–5. Besides other treat-
ments, many studies confirmed the im-
portance of aggressive lowering of the
plasma lipids in the primary and second-
ary prevention of the CHD6,7. In recent
available literature, the data about influ-
ence of combined exercise training, diet
and hypolipidemic medication therapy
during stationary cardiac rehabilitation
on the plasma lipids level of the patients
with CHD lacked.
Therefore, the aim of this study was to
investigate the effect of 3-weeks stationa-
ry cardiac rehabilitation on plasma lipids
level in patients with CHD.
Patients and methods
Patients eligible for this prospective
study were 467 patients with CHD during
3-weeks stationary cardiac rehabilitation
(mean duration 19±2 day). There were
332 (71%) patients who had myocardial
infarction (MI), 117 patients (25%) who
underwent coronary artery bypass grafting
(CABG) and 18 patients (4%) who under-
went percutaneous coronary intervention
(PCI), respectively. The average body
weight of the patients were 83±14 kg and
average body mass index (BMI) were
27.6±3.3 (range 21.1– 36.5). Seventy-eight
percent of the patients had BMI = 25 and
18% had BMI = 30, respecitvely. The pa-
tients were acquainted with the protocol
of the study and written informed consent
was obtained from the each patient.
Blood samples were taken in every pa-
tient the next day after admission and at
the last day of rehabilitation. The patients
were divided into the groups dependent
on their baseline values of Total choleste-
rol8 and medication therapy before the
start of the rehabilitation. The design of
the study is present on the Figure 1.9 Me-
dication during rehabilitation is present
in Table 1.
Plasma Total cholesterol and triglyce-
rides levels were determined by enzymatic
colorimetric (PAP) method. LDL-choleste-
rol level was calculated by using Friede-
wald formula (LDL cholesterol (mmol/l) =
Total cholesterol – triglycerides/2.2 – HDL-
-cholesterol)10 and HDL- cholesterol level
was determined by using selective precip-
itation method with magnesium chloride.
After determination of baseline lipid
profile, the patients started with rehabili-
tation. Rehabilitation program included
conditioning on cycle ergometer, supervi-
sed group exercise and distance limited
exercise walking. Rehabilitation was prac-
tized six days a week, with resting on
Sunday’s. Exercise level on cycle ergome-
ter was determined according to the re-
sults of the symptom – limited exercise
test at admission. Symptom – limited ex-
ercise test was done on cycle ergometer
with initial workload of 25 W which prog-
ressive increase for 25 W each 2 minutes.
In general, the intensity of daily exercise
of the patients on the cycle ergometer we-
re 70–85% of their peak heart rate achie-
ved on the initial exercise test. The condi-
tioning on cycle ergometer was started
the next day after the initial exercise test,
two times daily. On the first day, patients
started conditioning with 6 one minute
rounds, with one minute resting between
every round. If there were no contraindi-
cations, every 3 days the number of one
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minute round were progressively increa-
sed up to a maximum number of 14. Besi-
des conditioning on cycle ergometer, group
exercise of breathing, stretching, relaxa-
tion, muscle strenghthing were done un-
der supervision of a physiotherapist du-
ration of 30 minutes daily. Furthermore,
the distance-limited walking (1500 up to
2500 m at the end of rehabilitation) were
also done daily under supervision of a
physiotherapist. Diet comprised the re-
duction of the overall energy intake on
approximately 1600 ccal per day with up
to 35% nonsaturated fatty acid.
Statistical analysis was performed by
using the commercial software package,
SPSS for Windows, Version 10.0. The re-
sults are expressed by mean values ±
standard deviation and percentage of
change of each plasma lipids level at the
end of rehabilitation in comparison with
baseline values. The differences between
the groups were tested by analysis of va-
riance with repeated measures. The va-
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ELIGIBLE PATIENTS
(n = 467 patients)
372 male and 95 female, mean age of pts. 58 ± 9 year
EXCLUDED (n= 23 patients)
1. Did not finish the rehabilitation
program (n=16 patients)
2. Did not comply with the diet
(n=2 patients)




364 male and 80 female
GROUP I GROUP II
Normal baseline level of Elevate baseline level of
cholesterol (< 5 mmol/l) cholesterol (> 5 mmol/l)
(n= 129 patients) (n= 315 patients)
SUBGROUPS SUBGROUPS
Ia Ib IIa IIb
(with statin) (without statin)(with statin)(without statin)
(n=82 patients) (n=47 patients) (n=153 patients) (n=162 patients)
Fig. 1. The diagram of the study design.
lue of p<0.05 was considered statistically
significant.
Results
After 3-weeks cardiac rehabilitation,
the levels of Total cholesterol 5.75±1.34
vs. 5.17±1.08 mmol/l; p<0.001, triglyceri-
des 2.04±1.33 vs. 1.81±1.06 mmol/L; p=
0.004, LDL-cholesterol 3.77±1.14 vs. 3.21
±0.96 mmol/L; p<0.001 were significantly
lower while the level of HDL-cholesterol
0.94±0.28 vs. 0.99±0.27 mmol/L; p=0.008
were significantly higher in comparison
with the baseline values. We found signif-
icant changes in lipid profile at the end of
rehabilitation in each group of patients
compared with the baseline values (Table
2.). Furthermore, there were no significa-
nt differences in the baseline and level of
plasma lipids at the end of rehabilitation
between patients in the group Ia vs. Ib or
IIa vs IIb, respectively.
Discussion
The results of this study clearly show
that already after 3-weeks moderate reg-
ular physical activity and diet, the level
of Total cholesterol, triglycerides and
LDL-cholesterol significantly decreased
while the level of HDL-cholesterol signifi-
cantly increased. These results are in ac-
cordance with the previous studies which
pointed that physical activity and diet
have a favourable effect on the plasma li-
pids level11–14. Besides exercise and diet,
by including some of the hypolipidemic
drugs in the medication therapy, it could
obtain a more favourable effect on the re-
gulation of the plasma lipids level. It is
interesting that we found that regular ex-
ercise improved lipid profiles similarly in
patients with statin in therapy and in pa-
tients without statin. The study of Blu-
menthal J.A. et al. suggests that the in-
tensity of the exercise training have no
significant influence on the plasma lipids
level of the CHD patients, meaning that
exercise training of low intensity have a
similar effect on the plasma lipids level li-
ke exercise training of high intensity15.
Furthermore, Lavie C.J. et al. reported
that cardiac rehabilitation have a favour-
able effect on the lipids profile of the very
elderly CHD patients, the patients who
are older than 75 16. Doubtless, regular
exercise training by decreasing the level
of Total cholesterol, triglycerides and
LDL-cholesterol and by increasing the le-
vel of HDL-cholesterol at least partially
affected on reduction of the late mortality
rate after MI17. Because of the effect of
the exercise training and other treatment
during rehabilitation, The Task Force on
the Management of Acute Myocardial In-
farction of the European Society of Cardi-
ology (ESC) recommended referring car-
diac rehabilitation to every patient after
acute phase of MI with left ventricular
dysfunction18.
During the last decade, attitude about
medication hypolipidemic therapy have
significantly changed. Previous opinions
about hypolipidemic therapy were contro-
versial because of the lack of the large
prospective studies about the influence of
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Beta adrenergic blockers 173 39
Diuretics 102 23
Long acting nitrates 121 27





Oral anticoagulants 53 12
those drugs on survival after MI. The
»4S« study (Scandinavian Simvastatin
Survival Study) published 19947 is first
and probably the most famous large pros-
pective study which shows the importan-
ce of the aggressive lowering of the Total
and LDL-cholesterol plasma level in the
secondary prevention of CHD. After »4S«
study, the investigators conducted and
published many studies about the influ-
ence of other statins on the reduction of
mortality and major coronary event rate.
In general, these studies confirmed that
»statin therapy« has played an important
role in the prevention of CHD with the
harmless of that long-term treatment
19–21. Today in clinical practice, the stan-
dard is that the patients with established
CHD and elevated plasma lipid levels be
treated with some dose of statin, but the
prescription of that group of drugs is also
recommend in the primary prevention of
CHD20. Furthermore, it is important to
emphasize that statins, beside lowering
the level of plasma lipids, have many ot-
her anty-atherosclerotic effects named
»pleiotropic« which is the additional rea-
son for the wide prescription of those
drugs22.
In conclusion, the results of this study
suggest that moderate regular physical
activity and diet alone or in combination
with hypolipidemic drugs already after 3
weeks have a favourable effect on plasma
lipids level and should be propagate in
the prevention of CHD. Taking into consi-
deration the results of this study and re-
commendation of the ESC18, we conclude
that the majority of the patients after
acute phase of MI, CABG or PCI should
routinely be referred to and encouraged
to attend cardiac rehabilitation progra-
ms. The ambulatory exercise and preven-
tive programs have to be continued to
preserve the beneficial effects of phase II
stationary cardiac rehabilitation.
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TABLE 2
THE PERCENTAGE OF CHANGE OF EACH PLASMA LIPID LEVEL AT THE END
OF REHABILITATION IN COMPARISON WITH BASELINE VALUES
Group
of pts.
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UTJECAJ TROTJEDNE STACIONARNE KARDIOLO[KE
REHABILITACIJE NA RAZINU LIPIDA PLAZME U 444 BOLESNIKA
S KORONARNOM BOLE[]U
S A @ E T A K
Normalizacija razine lipida u krvi ima va`nu ulogu u prevenciji koronarne bolesti.
Cilj rada bio je utvrditi utjecaj trotjedne stacionarne kardiolo{ke rehabilitacije na lipi-
dogram bolesnika s koronarnom bole{}u. U studiju su uklju~ena 444 uzastopna boles-
nika (364 mu{karca i 80 `ena) prosje~ne dobi 58±9 godina s koronarnom bole{}u tije-
kom provedbe trotjedne kardiolo{ke rehabilitacije. Ovisno o inicijalnim vrijednostima
kolesterola i medikamentnoj terapiji kod dolaska na rehabilitaciju, bolesnici su podije-
ljeni u skupine: bolesnici s inicijalno normalnim (<5 mmol/L, skupina I, 29% bolesni-
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ka), povi{enim vrijednostima kolesterola (>5 mmol/L, skupina II, 71% bolesnika) te
podskupine Ia i IIa (uz statin u terapiji) te Ib i IIb (bez statina u terapiji). Lipidogram
je odre|en prije po~etka te na kraju rehabilitacije. Rezultati su izra`eni srednjom vri-
jedno{}u ± standardna devijacija te postotkom promjene razine svake pojedine frakcije
lipida na kraju rehabilitacije u odnosu na inicijalne vrijednosti. U statisti~koj analizi
dobivenih rezultata je kori{tena analiza varijance s ponavljanim mjerenjima. Nakon
provedene trotjedne rehabilitacije, vrijednosti kolesterola (5.75±1.34 vs. 5.17±1.08
mmol/l; p<0.001), triglicerida (2.04±133 vs. 1.81±106 mmol/L; p=0.004), LDL- koleste-
rola (3.77±114 vs. 3.21±096 mmol/L; p<0,001) su bile zna~ajno ni`e dok su vrijednosti
HDL-kolesterola (0.94±0.28 vs. 0.99±0.27 mmol/L; p=0,008) bile zna~ajno vi{e u odno-
su na izmjerene inicijalne vrijednosti. Tako|er, unutar svih skupina bolesnika na|ene
su zna~ajne razlike u lipidogramu na kraju rehabilitacije u odnosu na inicijalne vrijed-
nosti. Nije bilo zna~ajne razlike u razini lipida plazme na kraju rehabilitacije izme|u
skupina bolesnika sa ili bez statina u terapiji. Rezultati ovog rada pokazuju da redoviti
umjereni fizi~ki trening i dijetna prehrana uz hipolipemi~ku medikamentnu terapiju
ve} nakon tri tjedna povoljno utje~u na pojedine frakcije serumskih lipida te ih treba
propagirati u prevenciji koronarne bolesti.
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